Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 
Google Secures Pentagon AI Deal for Classified Projects 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
MALVERN, Pa., May 01, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage dermatologist-led biotechnology company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:
- Management will host investor meetings during the William Blair Late Stage Conference in New York, NY on Wednesday, May 10, 2017.
- Management will host investor meetings during the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas, NV on Wednesday and Thursday, May 17 and 18, 2017.
- Dr. Neal Walker, President and Chief Executive Officer, will present at Jefferies Global Healthcare Conference in New York, NY on Thursday, June 8, 2017 at 3:30 PM EDT.
- Dr. Walker will also present at William Blair Growth Stock Conference in Chicago, IL, on Tuesday, June 13, 2017 at 7:30 AM CDT.
- Management will host investor meetings during the JMP Securities Life Sciences Conference in New York, NY on Tuesday, June 20, 2017.
A live webcast of the Jefferies Global Healthcare Conference and the William Blair Growth Stock Conference presentations may be accessed through the Company's web site, www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the presentation will be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led biotechnology company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 [email protected] Media Contact Mariann Caprino TogoRun 917-242-1087 [email protected]
